New York, NY (PRWEB) April 02, 2013
The first book in The EQUITY Series, EQUITY of EVIL, quickly catapulted to the top of the charts on Amazon as the #1 Medical Thriller based on Average Customer Reviews. Three literary awards, including the 2012 Global eBook Award for Best Suspense Thriller, further enhanced the brand recognition of this debut novel. With growing momentum in a competitive industry, Mazzocchi is quickly following with the release of his second novel that seems to promise the same suspense, intensity and international intrigue.
EQUITY of FEAR, published by Twilight Times Books (Kingsport, TN), was released on March 25, 2013 in eBook format and will be available as a print edition in July. As with the first thriller in this series, EQUITY of EVIL, Mazzocchi once again pulls from personal business experiences to build a story of suspense – this time based on the medical science of neuroplasticity, the rewiring of the brain.
Synopsis of EQUITY of FEAR:
Researchers and scientists in the U.S., Russia and Japan compete in a new technological race to control fear and pain in the minds of the world’s populace. At first, the race is rooted in purely scientific ambitions, such as that of space travel or in the era of industrial revolution, but it evolves into something much more sinister.
What might governments or powerful organizations do or pay for the keys to control the fear of pain or the fear of death? What limits would prevent them from eliminating anything or anyone standing in the way? How far would they go to control the monopoly over a technology that could subliminally control the human brain, and what power would they have over the lives of billions, if successful?
Copyright©2012 Vocus, Inc.
All rights reserved